Cargando…

Securinine, a Myeloid Differentiation Agent with Therapeutic Potential for AML

As the defining feature of Acute Myeloid Leukemia (AML) is a maturation arrest, a highly desirable therapeutic strategy is to induce leukemic cell maturation. This therapeutic strategy has the potential of avoiding the significant side effects that occur with the traditional AML therapeutics. We ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Kalpana, Chakrabarti, Amitabha, Rana, Sonia, Ramdeo, Ritu, Roth, Bryan L., Agarwal, Munna L., Tse, William, Agarwal, Mukesh K., Wald, David N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123298/ https://www.ncbi.nlm.nih.gov/pubmed/21731671 http://dx.doi.org/10.1371/journal.pone.0021203

Ejemplares similares

The role of TLR8 signaling in Acute Myeloid Leukemia Differentiation
por: Ignatz-Hoover, James J, et al.
Publicado: (2014)

N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: Potential for cancer therapy
por: Amin, A.R.M. Ruhul, et al.
Publicado: (2012)

Induction of differentiation of the acute myeloid leukemia cell line (HL-60) by a securinine dimer
por: Hou, Wen, et al.
Publicado: (2020)

Novel bivalent securinine mimetics as topoisomerase I inhibitors
por: Hou, Wen, et al.
Publicado: (2017)

Antifungal Activity of Nor-securinine Against Some Phytopathogenic Fungi
por: Sahni, Sangita, et al.
Publicado: (2005)

Antifungal Activity of Securinine against Some Plant Pathogenic Fungi
por: Singh, Ashok K., et al.
Publicado: (2008)

New agents in acute myeloid leukemia (AML)
por: Park, Silvia, et al.
Publicado: (2020)

Unique indolizidine alkaloid securinine is a promising scaffold for the development of neuroprotective and antitumor drugs
por: Klochkov, Sergey, et al.
Publicado: (2021)

Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson's Disease
por: Leonoudakis, Dmitri, et al.
Publicado: (2017)

Proteomic and Systems Biology Analysis of Monocytes Exposed to Securinine, a GABA(A) Receptor Antagonist and Immune Adjuvant
por: Shipman, Matt, et al.
Publicado: (2012)

Collective total synthesis of C4-oxygenated securinine-type alkaloids via stereocontrolled diversifications on the piperidine core
por: Park, Sangbin, et al.
Publicado: (2022)

Securinine from Phyllanthus glaucus Induces Cell Cycle Arrest and Apoptosis in Human Cervical Cancer HeLa Cells
por: Stefanowicz-Hajduk, Justyna, et al.
Publicado: (2016)

Repression of GSK3 restores NK cell cytotoxicity in AML patients
por: Parameswaran, Reshmi, et al.
Publicado: (2016)

Emerging agents and regimens for AML
por: Liu, Hongtao
Publicado: (2021)

A Bivalent Securinine Compound SN3-L6 Induces Neuronal Differentiation via Translational Upregulation of Neurogenic Transcription Factors
por: Liao, Yumei, et al.
Publicado: (2018)

Chromosomal rearrangements in acute myeloid leukemia (AML)
por: Belloni, E, et al.
Publicado: (2010)

AngioCRIME in Acute Myeloid Leukemia (AML)
por: Macintyre, Elizabeth
Publicado: (2017)

The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)
por: Assouline, Sarit, et al.
Publicado: (2012)

Wnt signaling is involved in 6-benzylthioinosine-induced AML cell differentiation
por: Zang, Shaolei, et al.
Publicado: (2014)

PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML
por: Verbiest, Tom, et al.
Publicado: (2015)

Rational Combinations of Targeted Agents in AML
por: Bose, Prithviraj, et al.
Publicado: (2015)

Cutaneous Angiosarcoma Simulating as Pyoderma in a Middle-aged Indian female: A Rare Case Report
por: Rana, Shweta, et al.
Publicado: (2016)

New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
por: Chen, Jing, et al.
Publicado: (2020)

Acute Myeloid Leukemia (AML) with Erythroid Predominance Exhibits Clinical and Molecular Characteristics that Differ from Other Types of AML
por: Zuo, Zhuang, et al.
Publicado: (2012)

Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?
por: Webersinke, G, et al.
Publicado: (2014)

An unusual case of phenotype switch between AML FAB subtypes
por: Das, Animesh, et al.
Publicado: (2015)

Clinical Results of Hypomethylating Agents in AML Treatment
por: Cruijsen, Marjan, et al.
Publicado: (2014)

Chromatin Complexes Maintain Self-Renewal of Myeloid Progenitors in AML: Opportunities for Therapeutic Intervention
por: Uckelmann, Hannah J., et al.
Publicado: (2020)

Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML)
por: Cao, Ziyang, et al.
Publicado: (2022)

Sweet’s Syndrome (SS) in the Course of Acute Myeloid Leukaemia (AML)
por: Guarneri, Claudio, et al.
Publicado: (2018)

A Study of Cutaneous Adverse Drug Reactions and their Association with Autoimmune Diseases at a Tertiary Centre in South-West Rajasthan, India
por: Rana, Shweta, et al.
Publicado: (2021)

PB1863: VENETOCLAX AND HYPOMETHYLATING AGENT BASED OUTPATIENT AML INDUCTION- COST-EFFECTIVE METHOD FOR LMICS-REAL WORLD DATA FROM A TERTIARY CARE CENTER
por: Chauhan, Priyanka, et al.
Publicado: (2023)

Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
por: Mercher, Thomas, et al.
Publicado: (2019)

Immunophenotypic characterisation of morphologically diagnosed cases of Acute Myeloid Leukaemia (AML)
por: Basharat, Maria, et al.
Publicado: (2019)

Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
por: Guolo, Fabio, et al.
Publicado: (2022)

Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research
por: Skopek, Rafał, et al.
Publicado: (2023)

P1686: LONG-TERM COMORBIDITY AND HEALTH PROBLEMS IN ACUTE MYELOID LEUKEMIA (AML) SURVIVORS: AN INTERNATIONAL AML SURVIVORSHIP STUDY
por: Efficace, Fabio, et al.
Publicado: (2023)

Leukaemic pleural effusion as a manifestation of acute myeloid leukaemia: a case report and review of literature
por: Duhan, Amrita, et al.
Publicado: (2014)

Corrigendum: Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
por: Mercher, Thomas, et al.
Publicado: (2019)

Treatment of Low-Blast Count AML using Hypomethylating Agents
por: De Bellis, Eleonora, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vevbb6vrber4jqa3ogsspn1ipf